Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana R Sousa

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Acta Medica Portuguesa|May 15, 2023
Extracorporeal Membrane Oxygenation in an Adolescent with Multisystem Inflammatory Syndrome in ChildrenCristina Gago, Cristina Lorenzo, Sara Pinto, et al.
Pulmonary Pharmacology & Therapeutics|January 25, 2017
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler versus a multi-dose inhaler in patients with chronic obstructive pulmonary diseaseRobert Chan, Ana R Sousa, Peter Hynds, et al.
Respiratory Medicine|June 29, 2015
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studiesThomas M Siler, Edward Kerwin, Ana R Sousa, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2016
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthmaRobert Chan, Ana R Sousa, Stephen Mallett, et al.
NPJ Primary Care Respiratory Medicine|June 24, 2016
The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group studyAna R Sousa, John H Riley, Alison Church, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 2, 2023
Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in EnglandVictoria S Benson, Qinggong Fu, Shibing Yang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2011
Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen seasonPhilipp Badorrek, Melanie Dick, Hartmut Hecker, et al.
Pulmonary Therapy|February 7, 2020
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc AnalysisBernardino Alcázar Navarrete, Isabelle Boucot, Ian Naya, et al.
Polymers|November 25, 2023
Multifunctional Nanoparticles with Superparamagnetic Mn(II) Ferrite and Luminescent Gold Nanoclusters for Multimodal ImagingBárbara Casteleiro, Mariana Rocha, Ana R Sousa, et al.
Journal of Patient-Reported Outcomes|December 20, 2024
Chronic rhinosinusitis with nasal polyps (CRSwNP) symptom verbal response scales: content validity testing for use in adults with CRSwNPTom Keeley, Nina Gaw, Waseem Ahmed, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Acta Medica Portuguesa|May 15, 2023
Extracorporeal Membrane Oxygenation in an Adolescent with Multisystem Inflammatory Syndrome in ChildrenCristina Gago, Cristina Lorenzo, Sara Pinto, et al.
Pulmonary Pharmacology & Therapeutics|January 25, 2017
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler versus a multi-dose inhaler in patients with chronic obstructive pulmonary diseaseRobert Chan, Ana R Sousa, Peter Hynds, et al.
Respiratory Medicine|June 29, 2015
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studiesThomas M Siler, Edward Kerwin, Ana R Sousa, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2016
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthmaRobert Chan, Ana R Sousa, Stephen Mallett, et al.
NPJ Primary Care Respiratory Medicine|June 24, 2016
The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group studyAna R Sousa, John H Riley, Alison Church, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 2, 2023
Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in EnglandVictoria S Benson, Qinggong Fu, Shibing Yang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 5, 2011
Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen seasonPhilipp Badorrek, Melanie Dick, Hartmut Hecker, et al.
Pulmonary Therapy|February 7, 2020
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc AnalysisBernardino Alcázar Navarrete, Isabelle Boucot, Ian Naya, et al.
Polymers|November 25, 2023
Multifunctional Nanoparticles with Superparamagnetic Mn(II) Ferrite and Luminescent Gold Nanoclusters for Multimodal ImagingBárbara Casteleiro, Mariana Rocha, Ana R Sousa, et al.
Journal of Patient-Reported Outcomes|December 20, 2024
Chronic rhinosinusitis with nasal polyps (CRSwNP) symptom verbal response scales: content validity testing for use in adults with CRSwNPTom Keeley, Nina Gaw, Waseem Ahmed, et al.
Pageof 8